The interleukin 23 receptor gene in multiple sclerosis: A case-control study

Journal of Neuroimmunology

Volumn 194, Issue 1-2, 2008, Pages 173-180

  Roos, Izaura M ^a   Kockum, Ingrid ^a   Hillert, Jan ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Candidate gene; Case control; IL23R; Multiple sclerosis; Polymorphism; Tag SNP

Indexed keywords

INTERLEUKIN 23;

ARTICLE; CONTROLLED STUDY; ENTERITIS; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC CODE; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; FEMALE; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, INTERLEUKIN;

EID: 40049083702     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2007.11.011     Document Type: Article

References (42)

1. Anaya J.M., Castiblanco J., Tobon G.J., Garcia J., Abad V., Cuervo H., Velasquez A., Angel I.D., Vega P., and Arango A. Familial clustering of autoimmune diseases in patients with type 1 diabetes mellitus. J. Autoimmun. 26 (2006) 208-214
2. Anaya J.M., Tobon G.J., Vega P., and Castiblanco J. Autoimmune disease aggregation in families with primary Sjogren's syndrome. J. Rheumatol. 33 (2006) 2227-2234
3. Barrett J.C., Fry B., Maller J., and Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21 (2005) 263-265
4. Becker K.G., Simon R.M., Bailey-Wilson J.E., Freidlin B., Biddison W.E., Mcfarland H.F., and Trent J.M. Clustering of non-major histocompatibility complex susceptibility candidate loci in human autoimmune diseases. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 9979-9984
5. Begovich A.B., Carlton V.E., Honigberg L.A., Schrodi S.J., Chokkalingam A.P., Alexander H.C., Ardlie K.G., Huang Q., Smith A.M., Spoerke J.M., Conn M.T., Chang M., Chang S.Y., Saiki R.K., Catanese J.J., Leong D.U., Garcia V.E., Mcallister L.B., Jeffery D.A., Lee A.T., Batliwalla F., Remmers E., Criswell L.A., Seldin M.F., Kastner D.L., Amos C.I., Sninsky J.J., and Gregersen P.K. A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am. J. Hum. Genet. 75 (2004) 330-337
6. Bennett S.T., Lucassen A.M., Gough S.C.L., Powell E.E., Undlien D.E., Pritchard L.E., Merriman M.E., Kawaguchi Y., Dronsfield M.J., Pociot F., Nerup J., Bouzekri N., Cambon-Thomsen A., Ronningen K.S., Barnett A.H., Bain S.C., and Todd J.A. Susceptibility to human type 1 diabetes at IDDM2 is determined by tandem repeat variation at the insulin gene minisatellite locus. Nat. Genet. 9 (1995) 284-292
7. Bottini N., Musumeci L., Alonso A., Rahmouni S., Nika K., Rostamkhani M., Macmurray J., Meloni G.F., Lucarelli P., Pellecchia M., Eisenbarth G.S., Comings D., and Mustelin T. A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat. Genet. 36 (2004) 337-338
8. Broadley S.A., Deans J., Sawcer S.J., Clayton D., and Compston D.A.S. Autoimmune disease in first-degree relatives of patients with multiple sclerosis: a UK survey. Brain 123 (2000) 1102-1111
9. Celius E.G., and Vandvik B. Multiple sclerosis in Oslo, Norway: prevalence on 1 January 1995 and incidence over a 25-year period (2001)
10. de Bakker P.I.W., Yelensky R., Pe'er I., Gabriel S.B., Daly M.J., and Altshuler D. Efficiency and power in genetic association studies. Nat. Genet. 37 (2005) 1217-1223
11. Duerr R.H., Taylor K.D., Brant S.R., Rioux J.D., Silverberg M.S., Daly M.J., Steinhart A.H., Abraham C., Regueiro M., Griffiths A., Dassopoulos T., Bitton A., Yang H., Targan S., Datta L.W., Kistner E.O., Schumm L.P., Lee A.T., Gregersen P.K., Barmada M.M., Rotter J.I., Nicolae D.L., and Cho J.H. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 314 (2006) 1461-1463
12. Gabriel S.B., Schaffner S.F., Nguyen H., Moore J.M., Roy J., Blumenstiel B., Higgins J., Defelice M., Lochner A., Faggart M., Liu-Cordero S.N., Rotimi C., Adeyemo A., Cooper R., Ward R., Lander E.S., Daly M.J., and Altshuler D. The structure of haplotype blocks in the human genome. Science 296 (2002) 2225-2229
13. Green C., Elliott L., Beaudoin C., and Bernstein C.N. A population-based ecologic study of inflammatory bowel disease: searching for etiologic clues. Am. J. Epidemiol. 164 (2006) 615-623
14. Gregersen P.K., Lee H.S., Batliwalla F., and Begovich A.B. PTPN22: setting thresholds for autoimmunity. Semin. Immunol. 18 (2006) 214-223
15. Gregory S.G., Schmidt S., Seth P., Oksenberg J.R., Hart J., Prokop A., Caillier S.J., Ban M., Goris A., Barcellos L.F., Lincoln R., Mccauley J.L., Sawcer S.J., Compston D.A.S., Dubois B., Hauser S.L., Garcia-Blanco M.A., Pericak-Vance M.A., and Haines J.L. Interleukin 7 receptor [alpha] chain (IL7R) shows allelic and functional association with multiple sclerosis. Nat Genet 39 (2007) 1083-1091
16. Hampe J., Cuthbert A., Croucher P.J.P., Mirza M.M., Mascheretti S., Fisher S., Frenzel H., King K., Hasselmeyer A., Macpherson A.J.S., Bridger S., Van Deventer S., Forbes A., Nikolaus S., Lennard-Jones J.E., Foelsch U.R., Krawczak M., Lewis C., Schreiber S., and Mathew C.G. Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations. Lancet 357 (2001) 1925-1928
17. Hugot J.-P., Chamaillard M., Zouali H., Lesage S., Cezard J.-P., Belaiche J., Almer S., Tysk C., O'morain C.A., Gassull M., Binder V., Finkel Y., Cortot A., Modigliani R., Laurent-Puig P., Gower-Rousseau C., Macry J., Colombel J.-F., Sahbatou M., and Thomas G. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411 (2001) 599-603
18. Julier C., Hyer R.N., Davies J., Merlin F., Soularue P., Briant L., Cathelineau G., Deschamps I., Rotter J.I., Froguel P., Boitard C., Bell J.I., and Lathrop G.M. Insulin-IGF2 region on chromosome 11p encodes a gene implicated in HLA-DR4-dependent diabetes susceptibility. Nature 354 (1991) 155-159
19. Landtblom A.M., Riise T., and Kurtzke J.F. Further considerations on the distribution of multiple sclerosis in Sweden (2005)
20. Langrish C.L., Chen Y., Blumenschein W.M., Mattson J., Basham B., Sedgwick J.D., Mcclanahan T., Kastelein R.A., and Cua D.J. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 201 (2005) 233-240
21. Lucassen A.M., Julier C., Beressi J.-P., Boitard C., Froguel P., Lathrop M., and Bell J.I. Susceptibility to insulin dependent diabetes mellitus maps to a 4.1 kb segment of DNA spanning the insulin gene and associated VNTR. Nat. Genet. 4 (1993) 305-310
22. Lundmark F., Duvefelt K., Iacobaeus E., Kockum I., Wallstrom E., Khademi M., Oturai A., Ryder L.P., Saarela J., Harbo H.F., Celius E.G., Salter H., Olsson T., and Hillert J. Variation in interleukin 7 receptor [alpha] chain (IL7R) influences risk of multiple sclerosis. Nat. Genet. 39 (2007) 1108-1113
23. Marta, M., Becanovic, K., Stridh, P., Jagodic, M., Öckinger, J., Lorentzen, J. C., Olsson, T., submitted for publication. Analyses of a 58 Mb region on rat chromosome 4 reveal five distinct loci, Eae24-Eae28, and epistatic interactions in experimental autoimmune encephalomyelitis.
24. Murphy C.A., Langrish C.L., Chen Y., Blumenschein W., Mcclanahan T., Kastelein R.A., Sedgwick J.D., and Cua D.J. Divergent pro-and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J. Exp. Med. 198 (2003) 1951-1957
25. O'Connell J.R., and Weeks D.E. PedCheck: a program for identification of genotype incompatibilities in linkage analysis. Am. J. Hum. Genet. 63 (1998) 259-266
26. Ogura Y., Bonen D.K., Inohara N., Nicolae D.L., Chen F.F., Ramos R., Britton H., Moran T., Karaliuskas R., Duerr R.H., Achkar J.-P., Brant S.R., Bayless T.M., Kirschner B.S., Hanauer S.B., Nunez G., and Cho J.H. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 411 (2001) 603-606
27. Polman C.H., Reingold S.C., Edan G., Filippi M., Hartung H.-P., Kappos L., Lublin F.D., Metz L.M., Mcfarland H.F., O'connor P.W., Sandberg-Wollheim M., Thompson A.J., Weinshenker B.G., and Wolinsky J.S. Diagnostic criteria for multiple sclerosis: 2005 revisions to the McDonald Criteria. Ann. Neurol. 58 (2005) 840-846
28. Poser C.M., Paty D.W., Scheinberg L., Mcdonald W.I., Davis F.A., Ebers G.C., Johnson K.P., Sibley W.A., Silberberg D.H., and Tourtellotte W.W. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann. Neurol. 13 (1983) 227-231
29. Purcell S., Neale B., Todd-Brown K., Thomas L., Ferreira M.R., Bender D., Maller J., Sklar P., de Bakker P.W., Daly M., and Sham P. PLINK: A Tool Set for Whole-Genome Association and Population-Based Linkage Analyses (2007)
30. Purcell S., Cherny S.S., and Sham P.C. Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics 19 (2003) 149-150
31. Qin Z.S., Niu T., and Liu J.S. Partition-ligation-expectation-maximization algorithm for haplotype inference with single-nucleotide polymorphisms. Am. J. Hum. Genet. 71 (2002) 1242-1247
32. Reddy M., Velázquez-Cruz R., Baca V., Lima G., Granados J., Orozco L., and Alarcón-Riquelme M. Genetic association of IRF5 with SLE in Mexicans: higher frequency of the risk haplotype and its homozygozity than Europeans. Hum. Genet. 121 (2007) 721-727
33. Shin H., Sung Y.-K., Choi C.-B., Lee S., Lee H., and Bae S.-C. Replication of the genetic effects of IFN regulatory factor 5 (IRF5) on systemic lupus erythematosus in a Korean population. Arthritis Res. Ther. 9 (2007) R32
34. Sigurdsson S., Nordmark G., Goring H.H., Lindroos K., Wiman A.C., Sturfelt G., Jonsen A., Rantapaa-Dahlqvist S., Moller B., Kere J., Koskenmies S., Widen E., Eloranta M.L., Julkunen H., Kristjansdottir H., Steinsson K., Alm G., Ronnblom L., and Syvanen A.C. Polymorphisms in the tyrosine kinase 2 and interferon regulatory factor 5 genes are associated with systemic lupus erythematosus. Am. J. Hum. Genet. 76 (2005) 528-537
35. Smestad C., Brynedal B., Jonasdottir G., Lorentzen A.R., Masterman T., Akesson E., Spurkland A., Lie B.A., Palmgren J., Celius E.G., Hillert J., and Harbo H.F. The impact of HLA-A and -DRB1 on age at onset, disease course and severity in Scandinavian multiple sclerosis patients (2007)
36. Smyth D., Cooper J.D., Collins J.E., Heward J.M., Franklyn J.A., Howson J.M.M., Vella A., Nutland S., Rance H.E., Maier L., Barratt B.J., Guja C., Ionescu-Tirgoviste C., Savage D.A., Dunger D.B., Widmer B., Strachan D.P., Ring S.M., Walker N., Clayton D.G., Twells R.C.J., Gough S.C.L., and Todd J.A. Replication of an association between the lymphoid tyrosine phosphatase locus (LYP/PTPN22) with type 1 diabetes, and evidence for its role as a general autoimmunity locus. Diabetes 53 (2004) 3020-3023
37. Swanberg M., Lidman O., Padyukov L., Eriksson P., Akesson E., Jagodic M., Lobell A., Khademi M., Borjesson O., Lindgren C.M., Lundman P., Brookes A.J., Kere J., Luthman H., Alfredsson L., Hillert J., Klareskog L., Hamsten A., Piehl F., and Olsson T. MHC2TA is associated with differential MHC molecule expression and susceptibility to rheumatoid arthritis, multiple sclerosis and myocardial infarction. Nat. Genet. 37 (2005) 486-494
38. The International HapMap C. A haplotype map of the human genome. Nature 437 (2005) 1299-1320
39. Ueda H., Howson J.M., Esposito L., Heward J., Snook H., Chamberlain G., Rainbow D.B., Hunter K.M., Smith A.N., Di Genova G., Herr M.H., Dahlman I., Payne F., Smyth D., Lowe C., Twells R.C., Howlett S., Healy B., Nutland S., Rance H.E., Everett V., Smink L.J., Lam A.C., Cordell H.J., Walker N.M., Bordin C., Hulme J., Motzo C., Cucca F., Hess J.F., Metzker M.L., Rogers J., Gregory S., Allahabadia A., Nithiyananthan R., Tuomilehto-Wolf E., Tuomilehto J., Bingley P., Gillespie K.M., Undlien D.E., Ronningen K.S., Guja C., Ionescu-Tirgoviste C., Savage D.A., Maxwell A.P., Carson D.J., Patterson C.C., Franklyn J.A., Clayton D.G., Peterson L.B., Wicker L.S., Todd J.A., and Gough S.C. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 423 (2003) 506-511
40. Weng X., Liu L., Barcellos L.F., Allison J.E., and Herrinton L.J. Clustering of inflammatory bowel disease with immune mediated diseases among members of a northern California-managed care organization. Am. J. Gastroenterol. 102 (2007) 1429-1435
41. Yen D., Cheung J., Scheerens H., Poulet F., Mcclanahan T., Mckenzie B., Kleinschek M.A., Owyang A., Mattson J., Blumenschein W., Murphy E., Sathe M., Cua D.J., Kastelein R.A., and Rennick D. IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6. J. Clin. Invest. 116 (2006) 1310-1316
42. Zhang Z., Duvefelt K., Svensson F., Masterman T., Jonasdottir G., Salter H., Emahazion T., Hellgren D., Falk G., Olsson T., Hillert J., and Anvret M. Two genes encoding immune-regulatory molecules (LAG3 and IL7R) confer susceptibility to multiple sclerosis. Genes Immun. 6 (2005) 145-152